OpenAlex
PricingAboutJobs
Log inGet started
Work

Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis Care & Research
DOI: 10.1002/acr.21690
Authors: H. Ralph Schumacher, Robert R. Evans, Kenneth G. Saag, James Clower, William Jennings, Steven P. Weinstein, George D. Yancopoulos, Jian Wang, Robert Terkeltaub
Institutions: Philadelphia VA Medical Center, University of Pennsylvania, Regeneron (United States), University of Alabama at Birmingham, Westside Center for Clinical Research, University of California San Diego, VA San Diego Healthcare System
Language: English

Topic: Gout, Hyperuricemia, Uric Acid
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: rilonacept, IL-1 inhibitors, gout flares, urate-lowering therapy, allopurinol, serum uric acid, hyperuricemia, subcutaneous injection, injection site reactions, drug safety, efficacy, dose comparison, treatment discontinuation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2054682176
FWCI: 12.52
Cites: 46
Cited by: 130
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security